
Denali Therapeutics Inc.
USD19.66
+0.31 (+1.60%)
CEO
Ryan J. Watts
IPO Date
2017-12-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$19.34
Prev. Close
$19.35
Day Low
$19.19
Day High
$19.69
52W Low
$12.58
52W High
$23.77
Market Cap
$3.12B
Volume
1.01M
| 8 May 2026 |
| Wedbush |
| Outperform |
| Outperform |
| maintain |
| 22 Apr 2026 | Leerink Partners | Outperform | Outperform | maintain |
| 7 Apr 2026 | Baird | Outperform | Outperform | maintain |
| 26 Mar 2026 | Morgan Stanley | Overweight | Overweight | maintain |
| 26 Mar 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 26 Mar 2026 | Goldman Sachs | Buy | Buy | maintain |
| 26 Mar 2026 | Baird | Outperform | Outperform | maintain |